A tribute to Dr Ahmed Elsharkawy
The EASL community is deeply saddened by the loss of Dr Ahmed Elsharkawy, consultant transplant hepatologist, researcher, educator, and valued member of the EASL Governing Board. Ahmed served on the EASL Governing…
Press release: Alcohol abstinence can lead to regression of existing liver-related complications
Consistent and permanent abstinence from alcohol can lead to the regression of existing liver-related complications, even in cases of advanced alcohol-related cirrhosis. This is shown by an international multicenter study led by…
New A-TANGO Score for better patient stratification
We’re proud to share a major milestone for the A-TANGO Consortium: the latest publication is now available in the Journal of Hepatology: Highlights of this important publication: This study in global cohorts…
EASL Urges Support for WHO Resolution – “Steatotic Liver Disease – A Missing Piece in the Global Noncommunicable Disease Response”
Geneva, 18 February 2026 – The European Association for the Study of the Liver (EASL) has called on WHO Member States to support a landmark World Health Organization (WHO) draft resolution, “Steatotic…
LIVERAIM Webinar: Early detection of Chronic Liver Disease in primary care, Real-world perspectives
EASL invites you to watch this on-demand webinar bringing together leading experts from across Europe to explore why early detection of chronic liver disease must become a priority in primary care. Through…
Discover the THRIVE and GENIAL activities at EASL Liver Cancer Summit 2026
THRIVE ACTIVITIES AT EASL LIVER CANCER SUMMIT 2026 The overall aim of the THRIVE project is to improve the outcome of both paediatric and adult liver cancer patients by understanding at-risk…
Become part of the next generation of EASL’s leadership in 2026!
Are you deeply engaged in hepatology and science and ready to get involved in EASL’s governance? EASL is now looking to fill the following position: One Nurses & Allied Health Professionals (AHPs) Task Force Member…